Cargando…
High glucose inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via downregulation of v-ATPase V0 subunit d2 and dendritic cell-specific transmembrane protein
The balance between bone formation and resorption is compromised in diabetes, which may contribute to the high risk of fractures in diabetic patients. However, the mechanism by which high glucose affects bone turnover remains to be elucidated. The present study demonstrated that high glucose inhibit...
Autores principales: | XU, JUAN, YUE, FENG, WANG, JINGBO, CHEN, LI, QI, WENBO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262508/ https://www.ncbi.nlm.nih.gov/pubmed/25352342 http://dx.doi.org/10.3892/mmr.2014.2807 |
Ejemplares similares
-
V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis
por: Duan, Xiaohong, et al.
Publicado: (2018) -
Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and Function
por: Qin, An, et al.
Publicado: (2011) -
The V-ATPase a3 Subunit: Structure, Function and Therapeutic Potential of an Essential Biomolecule in Osteoclastic Bone Resorption
por: Chu, Anh, et al.
Publicado: (2021) -
Vγ9Vδ2 T cells inhibit immature dendritic cell transdifferentiation into osteoclasts through downregulation of RANK, c-Fos and ATP6V0D2
por: Zhu, Xiaolin, et al.
Publicado: (2018) -
Rational Identification of Enoxacin as a Novel V-ATPase-Directed Osteoclast Inhibitor
por: Toro, Edgardo J, et al.
Publicado: (2012)